Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease

NCT04656704 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI no longer pursuing clinical trial

Conditions

Microstomia
Scleroderma
CREST Syndrome
Scleromyxedema
Morphea

Interventions

DRUG: hyaluronidase injected intradermally

Sponsor

Brigham and Women's Hospital